2011 - 2020 of 8825 Results
Title
Year
-
RESTRICTEDTitle: Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tauJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.050391Citation Count: 2
-
OPENTitle: The global Alzheimer's Association round robin study on plasma amyloid β methodsJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 13Issue #: 1Start Page: e12242End Page: e12242Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/dad2.12242Best OA location URL: https://doi.org/10.1002/dad2.12242Citation Count: 35
-
RESTRICTEDTitle: Multiple sclerosis in 2019: predicting progressionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 12End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30441-7Citation Count: 1
-
OPENTitle: Movement disorders in 2019: from antibodies to lifestyle interventionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 10End Page: 12Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30438-7Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133486Citation Count: 1
-
OPENTitle: Patient-centred management of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 887End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30359-8Best OA location URL: http://www.thelancet.com/article/S1474442220303598/pdfCitation Count: 2
-
RESTRICTEDTitle: Wearable-based mobility monitoring: the long road aheadJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 5Start Page: 378End Page: 379Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30033-8Citation Count: 34
-
OPENTitle: A cornerstone initiative for progress in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30432-6Best OA location URL: http://www.thelancet.com/article/S1474442219304326/pdfCitation Count: 1
-
OPENTitle: Patient-centred management of Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 889End Page: 890Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30360-4Best OA location URL: http://www.thelancet.com/article/S1474442220303604/pdfCitation Count: 0
-
OPENTitle: Provisional case definitions for COVID-19-associated neurological diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 890End Page: 891Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30373-2Best OA location URL: http://www.thelancet.com/article/S1474442220303732/pdfCitation Count: 9
-
OPENTitle: Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30355-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6924570Citation Count: 1